News

Building a successful investment portfolio takes skill and hard work, no matter if you're a growth, value, income, or ...
Costco (COST) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the ...
Hurry – you can still get in early on our 10 top tickers for 2025. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception ...
Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) has earned a consensus recommendation of “Buy” from the eight ratings firms that are covering the firm, Marketbeat.com reports. Seven ...
Ovid Therapeutics Inc. (NASDAQ:OVID – Get Free Report) has earned a consensus rating of “Buy” from the seven brokerages that are covering the stock, Marketbeat Ratings reports. One investment analyst ...